Oxford-AstraZeneca

UK medicines regulator has approved the coronavirus vaccine developed by Oxford University and drugmaker AstraZeneca, for emergency supply. 

Clinical trial results showed that the jab is up to 90% effective in preventing COVID-19. 

This is the second vaccine to be approved in the UK after the Pfizer-BioNTech vaccine was given the go-ahead back in December. 

Britain has bought 100 million doses of the vaccine, and according to British Health Secretary Matt Hancock, the new jab will be rolled out from 4th January. 

Speaking to Sky News, Hancock said that the news “brings forward the day when we can get our lives back to normal.”

“We can say now with confidence that we can get out of this by spring.”

In a statement, AstraZeneca CEO Pascal Soriot said: “Today is an important day for millions of people in the UK who will get access to this new vaccine. It has been shown to be effective, well-tolerated, simple to administer and is supplied by AstraZeneca at no profit.”

Featured Image: AstraZeneca.com

Related

Heathrow Airport Departures

Pre-Christmas woes: Heathrow baggage handlers to strike from 16th December

December 2, 2022
by Arnas Lasys

The terminal from which Air Malta operates is set to be affected

Airplane Mode to become a thing of the past for intra-EU flights following new EU Commission decision

November 29, 2022
by Arnas Lasys

In a push for widespread adoption of 5G tech, passengers will be able to use their phone’s full capabilities in-flight

The end of pesky liquids restrictions in airport hand luggage? UK airports could ditch rules by 2024

November 24, 2022
by Helena Grech

The UK Government is considering rolling out more advanced scanners by mid-2024, sources told the BBC